Table 2.
Procedural details.
| Anesthesia | General: 15 (60%) Conscious sedation: 10(40%) |
| Access route | Femoral: 25 (100%) |
| Use of transesophageal | 16/25 (64%) |
| Echocardiogram | |
| LV wire | Amplatz super/extrastiff wire: 17/25 (64%), |
| Confida wire: 6/25 (24%), | |
| Lunderquist wire: 2/25 (8%) | |
| Preprocedure vascular cutdown | Nil |
| Preprocedure proglide | 25/25 (100%) |
| Predilatation | Evolut R/Core valve: 5 |
| Sapien 3: 5 | |
| Valve type | Evolut R: 15 (60%) |
| SAPIEN 3: 7 (28%) | |
| Core valve: 2 (8%) | |
| Balloon-expandable study valve: 1 (4%) | |
| Valve size | 23 mm: 6/25 patients (24%) |
| 26 mm: 11/25 patients (44%) | |
| 29 mm: 8/25 patients (32%) | |
| Paravalvular leak | Severe PVL: Nil |
| Moderate PVL: 3 (12%) | |
| Mild PVL: 11 (44%) | |
| No PVL: 11 (44%) | |
| Postdilatation required | 3 (12%) |
| Immediate postprocedure mean LV ejection fraction | 55.4 ± 9.4% |
| Immediate postprocedure mean aortic valve gradient | 8.5 ± 4.9 mmHg |
| Procedural success | 25/25 (100%) |
Data are presented as mean ± SD or as number and percentage.
LV, left ventricle; PVL, paravalvular leak.